Women's cancer drugs

These companies develop or sell drugs that treat breast, ovarian, endometrial and cervical cancers.
−29.9%
over 3 months · S&P 500 −2.1%

Key indicators

Health
50 / 100
Fragile
Solid
Price
P/E 26
Cheap
Expensive
Up over 1 year
6 of 12
Volatility
70%
Calm
Choppy
Health and price: against the other tags.